Epilepsia Open® Prize 2022 Basic Science
Morgan Sturgeon
Morgan Sturgeon (United States) was awarded the Epilepsia Open prize for her research, The opioid antagonist naltrexone decreases seizure-like activity in genetic and chemically induced epilepsy models.
Sturgeon ML, Langton R, Sharma S, Cornell RA, Glykys J, Bassuk AG. The opioid antagonist naltrexone decreases seizure‐like activity in genetic and chemically induced epilepsy models. Epilepsia Open. 2021;6(3):528-538. doi:10.1002/epi4.12512
An interview with Morgan Sturgeon, 2022 Epilepsia Open prize winner for basic science research
Subscribe to the ILAE Newsletter
To subscribe, please click on the button below.
Please send me information about ILAE activities and other
information of interest to the epilepsy community